Risk factors for acute kidney injury in pediatric patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis
Related Experiment Video
Updated: Jul 12, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Baoyi Huang1, Jiayi Shan1, Lichen Yi1
1Guangzhou University of Chinese Medicine, Guangzhou, China.
Insights
Pediatric acute kidney injury (AKI) after hematopoietic stem cell transplantation (HSCT) is common. Unrelated donors, cord blood stem cell transplantation, and VOD/SOS are potential risk factors for AKI in children undergoing HSCT.
Area of Science:
- Pediatric Hematology
- Nephrology
- Transplantation Medicine
Background:
- Acute kidney injury (AKI) is a significant complication following hematopoietic stem cell transplantation (HSCT) in pediatric patients, with risk factors often debated.
- Identifying these risk factors is crucial for improving patient outcomes and developing targeted interventions.
Approach:
- A systematic review and meta-analysis was conducted, searching multiple databases (PubMed, Embase, Web of Science, Cochrane Library, Scopus) up to February 8, 2023.
- Included studies were case-control, cohort, or cross-sectional designs involving pediatric patients (≤21 years) undergoing HSCT, with a minimum of ten patients.
- Quality assessment and random-effect modeling were employed to synthesize data from fifteen high-quality cohort studies involving 2,093 patients.
Key Points:
- The pooled incidence of AKI post-HSCT in children was found to be 47.4%.
- Significant risk factors identified for AKI include the use of an unrelated donor (OR=1.74), cord blood stem cell transplantation (OR=3.14), and veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) (OR=6.02).
- Factors such as myeloablative conditioning (MAC), acute graft-versus-host disease (aGVHD), and calcineurin inhibitors (CNI) were not significantly associated with AKI.
Conclusions:
- Post-transplant AKI is a frequent complication in pediatric HSCT recipients.
- Unrelated donors, cord blood stem cell sources, and VOD/SOS are identified as potential contributors to AKI.
- Further extensive research is necessary to establish definitive conclusions due to heterogeneity in patient and transplantation characteristics.
Background:
Risk factors for acute kidney injury (AKI) in pediatric patients after hematopoietic stem cell transplantation (HSCT) remain controversial.
Objectives:
This study aimed to identify risk factors for AKI following HSCT in the pediatric population.
Data Sources:
PubMed, Embase, Web of Science, Cochrane Library, and Scopus databases were searched from inception to February 8, 2023.
Study Eligibility Criteria:
Studies meeting the following criteria were included: (1) The study was a case-control, cohort study, or cross-sectional design, (2) the study was performed among pediatric and young patients aged 21 years or younger undergoing HSCT, (3) the study measured at least one related factor for AKI after pediatric HSCT, (4) the study included a sample of at least ten patients, and (5) original articles published in English in peer-reviewed scientific journals.
Participants And Interventions:
Children who were undergoing pediatric HSCT.
Study Appraisal And Synthesis Methods:
We assessed the quality of the included studies and analyzed them with a random-effect model.
Results:
Fifteen studies with a total of 2,093 patients were included. All were cohort studies of high quality. The overall pooled incidence of AKI was 47.4% (95%CI 0.35, 0.60). We found significant associations between post-transplant AKI in pediatric patients and unrelated donor [odds ratio (OR) = 1.74, 95% confidence interval (CI) 1.09-2.79], cord blood stem cell transplantation (OR = 3.14, 95%CI 2.14-4.60), and veno-occlusive disease (VOD)/sinusoidal obstruction syndrome (SOS) (OR = 6.02, 95%CI 1.40-25.88). Other controversial factors such as myeloablative conditioning (MAC), acute graft vs. host disease (aGVHD), and the use of calcineurin inhibitors (CNI) were not found to be related to AKI after pediatric HSCT.
Limitations:
Results were limited mainly by heterogeneity in the characteristics of patients and transplantation.
Conclusions And Implications Of Key Findings:
Posttransplant AKI in children is a common complication. Unrelated donors, cord blood stem cell transplantation, and VOD/SOS might be risk factors for AKI after pediatric HSCT. Further large-scale studies are still needed to draw firm conclusions.
Systematic Review Registration Number:
CRD42022382361 A higher resolution version of the Graphical abstract is available as Supplementary information.
Related Concept Videos
Kidney Transplant I: Introduction
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care

